Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

India COVID-19 Update: Antivirals, Eyes On HCQ-Azithromycin Data

Cipla Among Firms Prepping Favipiravir, Remdesivir, Baloxavir Generics

Mar 22 2020

• By Anju Ghangurde

Coronavirus — Indian firms up activity around potential coronavirus treatments • Source: Shutterstock

Related Content

COVID-19 Study Of Gilead’s Remdesivir Using Ebola-Style Adaptive Platform Trial

Mar 17 2020

Sandoz, Teva And Mylan Step Up On Hydroxychloroquine

Mar 20 2020

Ipca gets first approval for HCQ in diabetes

Jan 02 2015

Related Companies

Cipla Limited

AbbVie Inc.

FUJIFILM Holdings Corp.

Zhejiang Hisun Pharmaceutical Co. Ltd.

Gilead Sciences, Inc.

Ipca Laboratories Ltd.

Alembic Pharmaceuticals Limited

Pfizer Inc.

Bayer AG

Teva Pharmaceutical Industries Ltd.

Novartis AG

Additional Topics

India Asia Pacific Research & Development Coronavirus COVID-19 Infectious Diseases BioPharmaceutical

More from R&D

More from Scrip

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.